Indegene Limited (BOM:544172)
India · Delayed Price · Currency is INR 599.75
-0.15 (-0.03%)
At close: Oct 28, 2026
Indegene Market Cap
Indegene has a market cap or net worth of 144.29 billion as of October 28, 2026. Its market cap has increased by 10.64% in one year.
Market Cap
144.29B
Enterprise Value
131.06B
Revenue
38.13B
Global Rank
n/a
Country Rank
n/a
PE Ratio
36.11
ChartMarket Cap Chart
Since May 9, 2024, Indegene's market cap has increased from 108.15B to 144.29B, an increase of 33.42%. That is a compound annual growth rate of 12.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 144.29B | 15.51% |
| Dec 31, 2025 | 124.91B | -13.52% |
| Dec 31, 2024 | 144.45B | 33.56% |
| May 9, 2024 | 108.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.20T |
| Divi's Laboratories | 2.52T |
| Zydus Lifesciences | 1.17T |
| Lenskart Solutions | 1.16T |
| Dr. Agarwal's Health Care | 151.09B |
| Alembic Pharmaceuticals | 150.74B |
| Vijaya Diagnostic Centre | 148.59B |
| Molbio Diagnostics | 145.87B |